Fursultiamine

Especificaciones

804-30-8Número CAS

212-357-1Número CE

N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-[(E)-5-hydroxy-3-(oxolan-2-ylmethyldisulfanyl)pent-2-en-2-yl]formamideNombre IUPAC

C17H26N4O3S2Fórmula química

398.5 g/molPeso molecular

FURSULTIAMINE; 804-30-8; Fursultiamin; TTFD; Thiamine tetrahydrofurfuryl disulfide; Fursultiamina; Judolor; Aliaron F; Fursultiaminum; Alinamin-f; Thiamin tetrahydrofurfuryl disulfide; 05J61265PX; Formamide, N-((4-amino-2-methyl-5-pyrimidinyl)methyl)-N-(4-hydroxy-1-methyl-2-(((tetrahydro-2-furanyl)methyl)dithio)-1-butenyl)-; DTXCID30809568; DTXSID0023084; Formamide, N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-[4-hydroxy-1-methyl-2-[[(tetrahydro-2-furanyl)methyl]dithio]-1-butenyl]-; Hydrochloride, Fursultiamin; Monohydrochloride, Fursultiamin; N-((4-amino-2-methylpyrimidin-5-yl)methyl)-N-((2E)-5-hydroxy-3-(((oxolan-2-yl)methyl)disulfanyl)pent-2-en-2-yl)formamide; N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-[(2E)-5-hydroxy-3-{[(oxolan-2-yl)methyl]disulfanyl}pent-2-en-2-yl]formamide; Disulfide, Thiamine Tetrahydrofurfuryl; RefChem:388994; 212-357-1; Alinamin F; Linamin; MFCD00867383; Diteftin; Formamide,N-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-N-[4-hydroxy-1-methyl-2-[[(tetrahydro-2-furanyl)methyl]dithio]-1-butenyl]-; N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-[(E)-5-hydroxy-3-(oxolan-2-ylmethyldisulfanyl)pent-2-en-2-yl]formamide; N-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-N-(4-hydroxy-1-methyl-2-((tetrahydrofurfuryl)dithio)-1-butenyl)formamide; N-((4-Amino-2-methylpyrimidin-5-yl)methyl)-N-(5-hydroxy-3-(((tetrahydrofuran-2-yl)methyl)disulfanyl)pent-2-en-2-yl)formamide; N-[(4-amino-2-methyl-pyrimidin-5-yl)methyl]-N-[(E)-4-hydroxy-1-methyl-2-(tetrahydrofuran-2-ylmethyldisulfanyl)but-1-enyl]formamide; Retar B1; Retar-B(sub 1); Fursultiamine [INN:JAN]; Tetrahydrofurfuryl thiamine disulfide; Fursultiaminum [INN-Latin]; Fursultiamina [INN-Spanish]; (E)-N-((4-amino-2-methylpyrimidin-5-yl)methyl)-N-(5-hydroxy-3-(((tetrahydrofuran-2-yl)methyl)disulfanyl)pent-2-en-2-yl)formamide; C17H26N4O3S2; EINECS 212-357-1; BRN 0052964; UNII-05J61265PX; NCGC00188432-01; N-((4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL)-N-((1E)-4-HYDROXY-1-METHYL-2-((TETRAHYDROFURAN-2-YLMETHYL)DISULFANYL)BUT-1-EN-1-YL)FORMAMIDE; N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-{(1E)-4-hydroxy-1-methyl-2-[(tetrahydrofuran-2-ylmethyl)disulfanyl]but-1-en-1-yl}formamide; Prestwick2_001007; Prestwick3_001007; FURSULTIAMINE [MI]; FURSULTIAMINE [INN]; FURSULTIAMINE [JAN]; SCHEMBL24002; BSPBio_001133; 5-25-12-00167 (Beilstein Handbook Reference); MLS006010098; FURSULTIAMINE [MART.]; FURSULTIAMINE [WHO-DD]; BPBio1_001247; orb1302764; CHEMBL1740659; SCHEMBL26670566; SCHEMBL29370705; CHEBI:91836; CHEBI:135636; GLXC-01621; HMS5085J10; 10238-39-8; HY-B2082; Tox21_112989; EBC-26947; AKOS015961066; AC-4505; CS-8111; DB08966; FT40945; NCGC00179291-01; NCGC00179291-04; AS-14765; CAS-804-30-8; Formamide, N-((4-amino-2-methyl-5-pyrimidinyl)methyl)-N-(4-hydroxy-1-methyl-2-((tetrahydrofurfuryl)dithio)-1-butenyl)-; SMR001827667; AB00443520; S6614; T4552; EN300-21702620; F806208; Q5509734; BRD-A71157293-003-03-5; BRD-A71157293-003-10-0; N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-[5-hydroxy-3-(oxolan-2-ylmethyldisulfanyl)pent-2-en-2-yl]formamideSinónimos